Sabin President Peter Hotez, M.D, Ph.D., was honored yesterday evening with B’nai B’rith International’s Distinguished Achievement Award for advancing science and humanity, his commitment to enlightened leadership, and community service.

Neglected tropical diseases (NTDs) are the most common affliction of the world’s poorest people. Thriving in communities that lack access to health services, adequate sanitation and clean water, NTDs blind, disable and disfigure, trapping families in a cycle of poverty and disease.

While investments in biomedical R&D have led to tremendous scientific breakthroughs and health improvements in the modern era, the benefits have been shared unevenly.

More than two billion people lack access to necessary medicines. High costs and limited health care infrastructure prevent many people from benefiting from recent medical advancements, leaving populations at risk of preventable diseases.

Sabin Vaccine Institute Joins Coalition Dedicated to Preventing Future Epidemics

Geneva, Switzerland – November 18, 2016 – Today, the Sabin Vaccine Institute (Sabin) begins its formal partnership with the Coalition for Epidemic Preparedness Innovations (CEPI), as a member of CEPI’s Joint Coordination Group (JCG). Global health leaders gather in Geneva, Switzerland for the first meeting of the JCG.

What the poor suffer from most happens in developed countries

While rarely talked about, Neglected Tropical Diseases are the most widespread ailment among the world's poorest of the poor – yet also ironically the most prevalent in top global economies, experts say.

Neglected Tropical Diseases (NTDs) are “the most important diseases you've never heard of. These are the most common afflictions of the world's poor,” Peter Hotez, MD, PhD, told CNA Nov. 11.

Catholic News Agency

Pope Francis, Sabin President Discuss Goals of the Catholic Church during Conference on Neglected Tropical Diseases

Vatican City – November 10, 2016 –Peter Hotez, M.D., Ph.D., president of the Sabin Vaccine Institute (Sabin) and director of the Sabin Product Development Partnership (Sabin PDP), today will help kick off the first-ever Vatican conference on neglected tropical diseases (NTDs) and rare diseases with a keynote address.

Sabin Vaccine Institute President Dr. Peter Hotez gave the keynote address on NTDs at the Pontifical Council for Health Care Workers’ XXXI International Conference, focused on NTDs and rare diseases.

Investments in research and development (R&D) are leading to tremendous scientific breakthroughs in health. Just in the last few years, scientists have made tremendous advancements. For several cancers, novel treatments have diminished deathly prognoses. New surgical techniques have reduced recovery time and leave scars smaller than a penny. Just within the last decade, the cost of DNA sequencing has declined so much that personalized medicine is on the cusp of becoming quotidian.

We are pleased to announce the Sabin Vaccine Institute will be participating in this year’s World Health Summit.

Pages

Subscribe to RSS - Research & Development